Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangyintongnao is a traditional Chinese medicine (TCM) formulation used primarily in China. It is typically administered as a granule and is designed to "tonify Qi and activate blood," which are TCM concepts referring to improving energy flow and circulation. Yangyintongnao is one of several TCM products (alongside Nao-Xin-Tong capsule and BYHW granule) used for these purposes[4]. The specific herbal composition of Yangyintongnao may vary by manufacturer, but it generally contains multiple plant-derived ingredients aimed at supporting cerebrovascular health, particularly in the context of ischemic cerebrovascular diseases such as stroke or chronic cerebral insufficiency[4][5][6]. Its mechanism of action from a biomedical perspective has not been fully elucidated; however, it likely involves modulation of blood flow, anti-inflammatory effects, neuroprotection, and possibly antioxidant activity based on the known actions of its constituent herbs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yangyintongnao.